Therapy for hepatitis C virus-related cryoglobulinemic vasculitis.

@article{Dammacco2013TherapyFH,
  title={Therapy for hepatitis C virus-related cryoglobulinemic vasculitis.},
  author={Franco Dammacco and Domenico Sansonno},
  journal={The New England journal of medicine},
  year={2013},
  volume={369 11},
  pages={
          1035-45
        }
}
Cryoglobulins are present in about a quarter of patients with hepatitis C; in some, cryoglobulinemia can become symptomatic or even life-threatening. This review summarizes evolving therapy for the disorder, including new therapeutic options that are becoming available. 

Paper Mentions

Interventional Clinical Trial
10 patients with chronic genotype 1 HCV infection and mixed cryoglobulinemia will be treated with Ledipasvir/Sofosbuvir 90mg/400 mg FDC once daily for 12 weeks (naïve subjects or… Expand
ConditionsCryoglobulinemia, Hepatitis C
InterventionDrug
Myopericarditis in a patient with hepatitis C and cryoglobulinemic renal disease
Although cryoglobulinemia is a well‐appreciated complication of hepatitis C (HC), myopericarditis with resulting pericardial effusion is extremely rare, especially in the absence of a liverExpand
A Rare Case of Hepatitis C-Associated Cryoglobulinemic Duodenal Vasculitis: 1113
TLDR
A woman admitted to a service for management of acute renal failure and progressive gas-trointestinal symptoms after initiating hepatitis C virus treatment with ribavirin and sofosbuvir is described, sparking suspicion for recurrence of cryo-globulinemic vasculitis. Expand
A Rare Case of Hepatitis C-Associated Cryoglobulinemic Duodenal Vasculitis
TLDR
A woman admitted to a service for management of acute renal failure and progressive gastrointestinal symptoms after initiating hepatitis C virus treatment with ribavirin and sofosbuvir is described, sparking suspicion for recurrence of cryoglobulinemic vasculitis. Expand
[Cryoglobulinemic vasculitis with renal involvement: A historic aspect of the problem].
TLDR
The paper shows advances in the study of the etiology of cryoglobulinemia, diagnosis, specific features of renal injury, and current approaches to treating HCV infection-relatedcryoglobulinemic vasculitis with renal involvement, by using 3 clinical cases. Expand
Effectiveness and cost of hepatitis C virus cryoglobulinaemia vasculitis treatment: From interferon‐based to direct‐acting antivirals era
The net benefits of new hepatitis C virus (HCV) direct‐acting antiviral drugs (DAA) in patients with cryoglobulinaemia vasculitis (CryoVas) are unknown.
Annular leukocytoclastic vasculitis associated with essential mixed cryoglobulinemia
Cryoglobulins are abnormal proteins and immunoglobulin complexes that precipitate from serum at temperatures below 37 C. Cryoglobulinemia has been associated with chronic infections as well asExpand
Impact of mixed cryoglobulinemia on patients with spontaneous hepatitis C virus clearance: A 13‐year prospective cohort study
The prevalence and associations of mixed cryoglobulinemia (MC) in patients with spontaneous clearance of hepatitis C virus (HCV) remain elusive.
A Devastating Case of Hepatitis C-Induced Mixed Cryoglobulinemia
Hepatitis C-induced mixed cryoglobulinemia leading to rapidly progressive gangrene, necessitating amputations, is a rare presentation. We describe a case of a 55-year-old man with untreated chronicExpand
Lymphoma-Associated Monoclonal Cryoglobulinemic Glomerulonephritis and Relationship with Hepatitis C Virus Infection: A Case Report
TLDR
The case of type I cryoglobulinemic glomerulonephritis in a patient with chronic hepatitis C who presented with acute renal failure exemplifies the crucial role the renal biopsy plays in detecting lymphoid malignancies where clinical features are ambiguous. Expand
A Case of Cryoglobulinemia after Successful Hepatitis C Virus Treatment
TLDR
It is rare for a patient who achieved sustained virologic response after HCV treatment to develop mixed cryoglobulinemia, and a rare case is presented in a patients who was successfully treated for HCV infection. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 97 REFERENCES
Persistent cryoglobulinemic vasculitis following successful treatment of hepatitis C virus.
TLDR
4 patients who had persistent MC and vasculitis despite successful eradication of HCV with antiviral therapy are described. Expand
Treatment of idiopathic mixed cryoglobulinemia with alpha interferon.
Seven patients with type II idiopathic mixed cryoglobulinemia were treated with recombinant human leukocyte interferon (alpha interferon). In all of them, a conspicuous reduction of circulatingExpand
Rituximab in cryoglobulinemic peripheral neuropathy
TLDR
Rituximab appeared to be effective and safe in the treatment of patients with type II cryoglobulinemia-associated neuropathy and a significant improvement in the clinical neuropathy disability score was observed. Expand
Mixed cryoglobulinemia
  • C. Ferri
  • Medicine
  • Orphanet journal of rare diseases
  • 2008
TLDR
The overall prognosis is poorer in patients with renal disease, liver failure, lymphoproliferative disease and malignancies, and the first-line treatment of MC should focus on eradication of HCV by combined interferon-ribavirin treatment. Expand
Rituximab as a Therapeutic Tool in Severe Mixed Cryoglobulinemia
TLDR
Rituximab appears to be a safe and effective therapeutic option in symptomatic patients with HCV-associated MC with signs of systemic vasculitis and a number of reports published in the last 5 years suggest this. Expand
Hepatitis C virus and alanine aminotransferase kinetics following B-lymphocyte depletion with rituximab: evidence for a significant role of humoral immunity in the control of viremia in chronic HCV liver disease.
TLDR
The use of the anti-CD20 monoclonal antibody rituximab, which reversibly depletes B cells, in HCV-related mixed cryoglobulinemia afforded an improvement in the clearance of hepatitis C virus from plasma. Expand
Recommendations for the management of mixed cryoglobulinemia syndrome in hepatitis C virus-infected patients.
TLDR
A core set of recommendations for the treatment of HCV-associated mixed cryoglobulinemia syndrome is defined by combining current evidence from clinical trials and expert opinion, and may be useful as provisional guidelines for the management of MCS. Expand
The cryoglobulins: an overview
TLDR
The higher risk of non‐Hodgkin's lymphoma (NHL) displayed by HCV positive subjects, especially in the Mediterranean basin, suggests that the HCV's chronic lymphoproliferative drive may progress towards frank lymphoid neoplasia. Expand
Safety and efficacy of rituximab in patients with hepatitis C virus-related mixed cryoglobulinemia and severe liver disease.
TLDR
The depletion of CD20(+) B cells was followed by cirrhosis syndrome improvement despite the possibility of transient increases of viremia titers, and the effectiveness and safety of rituximab in MC syndrome with advanced liver disease were shown. Expand
Relapse of hepatitis C virus-associated mixed cryoglobulinemia vasculitis in patients with sustained viral response.
TLDR
Relapse of MC vasculitis does occur in a few patients with HCV infection, despite achieving a sustained viral response, and this relapse is not related to persistence of virus. Expand
...
1
2
3
4
5
...